In previous canine studies, p-mTOR is not expressed in normal mammary tissues, but in 78% of mammary carcinomas, and the expression of the mTORC2 component Rictor is positively correlated with lymphatic invasion and poorer survival [159–161]. Here, MTOR is linked to breast carcinoma.